Skip to content

Emotions, Dopamine, Brain and Body

Influence of Domperidon on the Experience of Emotions, Brain and Bodily Activity

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06171087
Acronym
EMBODY
Enrollment
40
Registered
2023-12-14
Start date
2023-08-01
Completion date
2024-09-30
Last updated
2023-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emotions

Brief summary

The study will examine the influence of domperidon (20mg) on brain and hebavioral responses to emotional stimuli (videos) using fMRI

Interventions

oral

DRUGPlacebo

oral tablet

Sponsors

German Institute of Human Nutrition
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

Double blind, placebo controlled intervention with 20mg of Domperidon

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-40 years old men and women * Consent to participate * Fluent in German * Physically and mentally healthy. No regular medication * BMI 18-25 kg/m2 * Alcohol consumption less than 15 glasses a week (wine / beer, a glass of higher-percentage alcohol counts as two glasses of beer) * No illegal drug consumption in the week previous to the experiment * No smoking * No extreme athletes * No vegetarians or vegans or any other dietary restrictions due to allergies or intolerances * Normal day-night rhythm (no shift work)

Exclusion criteria

* Former or current illnesses of: * Brain or mind (including anxiety disorders, depression, eating disorders, personality disorders, alcohol, drugs or drug dependence, neurological disorders other than occasional headache, psychiatric or neurological abnormalities) * Heart or blood circulation * Gastro-intestinal or endocrine disorders * Other serious past or present medical conditions (for example, metabolic syndrome, diabetes). * Current medication and medication over a period of two weeks prior to the examination. * Other serious health problems or present strong mental or physical stress. * No current infection or excessive stress * Missing consent to receive information about incidental findings from the MRI * Tendency to claustrophobia, dizziness or panic attacks. * Wear a non-removable pacemaker, defibrillator, hearing aid, drug pump, neurostimulator or implant with solenoid valve (e.g., artificial bowel outlet). * Metal parts or implants inside the body, for example, due to surgery or injury with a metallic foreign object (e.g., hip replacements, artificial joints, heart valves, vessel occlusions or dilatations, surgical clips, bone screws or plates, coil, shunts, catheters, electrodes, coils, radiation sources, shrapnel, projectiles, stents). * Have non-removable metal parts or metal-containing devices on or in the body. * Have ferromagnetic metal parts or implants inside the body (e.g., hip replacements, artificial joints, heart valves, vessel occlusions or dilatations, surgical clips, bone screws or plates, coils, shunts, catheters, electrodes, coils, radiation sources, shrapnel, projectiles, stents) * Wearing magnetically fixed implants (e.g., amalgam fillings, glass eye). * Professionally or privately being involved in the processing of metals. * Have large tattoos (whole limbs). * Being pregnant. * Wear a intra-uterine device. * Having tinnitus. * Hypersensitivity or allergy to Domperidone or common excipients (lactose-1, corn Starch, potato starch, microcrystalline cellulose, castor oil, povidone, sodium lauryl sulfate, magnesium stearate, hypromellose)

Design outcomes

Primary

MeasureTime frameDescription
Brain responses to emotions1-3 hour after drug administratrionfMRI brain responses to emotional videos comparing placebo vs domperidon condition. Specifically: dampened brain response to disgust and high arousing videos in domperidon condition
Body (stomach, heart, skin conductance) response to emotions1-3 hour after drug administratrionPhysiological responses to emotional videos comparing placebo vs domperidon condition. Specifically: Reduction in Tachyhastria for disgust and high arousing videos in domperidone condition
Behavioral responses to emotions1-3 hour after drug administratrionChanges in subjective reports to emotional videos comparing placebo vs domperidon condition. Specifically: Reduction in disgust and arousal ratings to disgust and high arousing videos

Countries

Germany

Contacts

Primary ContactIgnacio Rebollo, PhD
ignacio.rebollo@dife.de0049 33200 8
Backup Contactsoyoung park, Prof PhD
soyoung.park@dife.de0049 33200 88

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026